TMOD2
Basic information
Region (hg38): 15:51751597-51816363
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMOD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 1 | 0 |
Variants in TMOD2
This is a list of pathogenic ClinVar variants found in the TMOD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-51766481-A-G | not specified | Uncertain significance (Jun 22, 2021) | ||
15-51766493-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
15-51768301-A-G | not specified | Uncertain significance (Nov 12, 2021) | ||
15-51768319-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
15-51768332-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
15-51773751-G-A | not specified | Likely benign (Jan 04, 2022) | ||
15-51773816-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
15-51773828-C-A | not specified | Uncertain significance (Sep 29, 2023) | ||
15-51776937-C-G | not specified | Uncertain significance (Apr 22, 2022) | ||
15-51781124-A-T | not specified | Uncertain significance (Dec 19, 2022) | ||
15-51781140-C-T | not specified | Uncertain significance (May 30, 2024) | ||
15-51781167-A-G | not specified | Uncertain significance (May 08, 2024) | ||
15-51782730-A-G | not specified | Uncertain significance (Dec 15, 2023) | ||
15-51782775-C-G | not specified | Uncertain significance (Feb 10, 2023) | ||
15-51782782-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
15-51782786-G-T | not specified | Uncertain significance (Apr 22, 2022) | ||
15-51782803-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
15-51782826-A-G | not specified | Uncertain significance (May 05, 2023) | ||
15-51798208-C-G | not specified | Uncertain significance (Oct 26, 2021) | ||
15-51798239-C-G | not specified | Uncertain significance (Nov 15, 2021) | ||
15-51798264-C-A | not specified | Uncertain significance (Jan 24, 2023) | ||
15-51798285-T-G | not specified | Uncertain significance (Aug 14, 2023) | ||
15-51806386-T-G | not specified | Uncertain significance (Dec 13, 2022) | ||
15-51806403-G-T | not specified | Uncertain significance (Jan 23, 2023) | ||
15-51806420-T-C | not specified | Uncertain significance (Aug 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TMOD2 | protein_coding | protein_coding | ENST00000249700 | 9 | 64808 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0196 | 0.977 | 125729 | 0 | 15 | 125744 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.391 | 169 | 184 | 0.919 | 0.00000904 | 2328 |
Missense in Polyphen | 50 | 60.059 | 0.83252 | 781 | ||
Synonymous | 0.778 | 59 | 67.1 | 0.879 | 0.00000340 | 658 |
Loss of Function | 2.55 | 6 | 17.5 | 0.342 | 9.05e-7 | 216 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000174 | 0.000174 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Blocks the elongation and depolymerization of the actin filaments at the pointed end. The Tmod/TM complex contributes to the formation of the short actin protofilament, which in turn defines the geometry of the membrane skeleton (By similarity). {ECO:0000250}.;
- Pathway
- Striated Muscle Contraction;Muscle contraction
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.291
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 17.75
Haploinsufficiency Scores
- pHI
- 0.336
- hipred
- Y
- hipred_score
- 0.558
- ghis
- 0.636
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.234
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tmod2
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- muscle contraction;neuron-neuron synaptic transmission;nervous system development;learning or memory;myofibril assembly;positive regulation of G protein-coupled receptor signaling pathway;pointed-end actin filament capping
- Cellular component
- striated muscle thin filament;myofibril;growth cone
- Molecular function
- actin binding;tropomyosin binding